
Where MedTech professionals gain clarity and confidence to navigate complex risk, quality, and leadership challenges.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 535 | Founded | 3 years ago | Last Issue | 3 days ago |
| Active | |||||

In responding to Comment #27 in the preamble of the QMSR1, FDA stated that a culture of quality meets regulatory requirements through a set of behaviors, attitudes, activities and processes.
FDA’s response suggests that a culture of quali...
Dear colleagues:
We often talk about risk-based decisions as if the main challenge is technical: gather the evidence, understand the tradeoff, and make the call.
But in matrix organizations, another problem often sits underneath the decis...
“Stop thinking of AI as replacing humans. Think about humans staying in charge while AI is placed in the loop”
Artificial intelligence is no longer a future concept in MedTech. It is already inside medical devices, quality sys...
In responding to Comment #27 in the preamble of the QMSR1, FDA stated that it expects medical device manufacturers, led by individuals with executive responsibilities, to embrace a culture of quality.
That phrase can sound broad, even soft...
Dear colleagues:
In MedTech, many organizations believe they have an active Post-Market Surveillance (PMS) process. But in practice, what they mostly have is vigilance.
They gather complaints, review events, and decide whether something m...
Subscribers, engagement, traffic and sponsorship for Let's Talk Risk!.
| Subscribers | Engagement | 71 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #178 |
The writers behind this newsletter.
MedTech risk management advisor, educator, and creator of Let’s Talk Risk! Sharing ideas on risk, quality, leadership, and decision-making under uncertainty.
You can find recent issues that have been published by Let's Talk Risk! on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Let's Talk Risk!, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Let's Talk Risk! as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Let's Talk Risk! using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Let's Talk Risk!. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.